-
| Industry | Medical Instruments & Supplies |
|---|---|
| Sector | Healthcare |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| ISIN | BE0974358906 |
| Target Price | 9.5225 |
|---|---|
| Market Cap | 128M |
| PE Ratio | None |
| Beta | 0.88 |
| Dividend Yield | None |
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NYXH using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026